[{"id":"a5fb916b-9f30-4f9d-9ea1-2ab138b877c9","acronym":"","url":"https://clinicaltrials.gov/study/NCT01091454","created_at":"2021-01-18T04:18:47.760Z","updated_at":"2024-07-02T16:37:10.922Z","phase":"Phase 2","brief_title":"Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer","source_id_and_acronym":"NCT01091454","lead_sponsor":"Alliance for Clinical Trials in Oncology","biomarkers":" HER-2","pipe":"","alterations":" ","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • brostallicin (PNU-166196)"],"overall_status":"Completed","enrollment":" Enrollment 48","initiation":"Initiation: 06/01/2010","start_date":" 06/01/2010","primary_txt":" Primary completion: 06/01/2012","primary_completion_date":" 06/01/2012","study_txt":" Completion: 11/01/2014","study_completion_date":" 11/01/2014","last_update_posted":"2018-05-08"}]